SMR Update with Dr. Keith Flaherty
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

SMR Update with Dr. Keith Flaherty

› Forums › General Melanoma Community › SMR Update with Dr. Keith Flaherty

  • Post
    • January 22, 2015 at 11:40 pm
    Anonymous
    Inactive

    Dear MPIP Community Members,

    Last week, Dr. Keith Flaherty recorded a webinar with us to provide an update on the research and key findings presented at the November 2014 SMR (Society for Melanoma Research) meeting held in Zurich, Switzerland. To access the webinar, please click here. Your name and email address are requested to track the number of visits only.

    If you have any questions, comments or topics for future webinars, please contact me directly at education@melanoma.org. Have a great evening!

    Sincerely,

    Shelby – MRF

    About Dr. Keith Flaherty

    Dr. Flaherty is director of the Henri and Belinda Termeer Center for Targeted Therapies at the Massachusetts General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Flaherty’s research and clinical focus is therapies for melanoma, with a particular expertise in targeted therapies.

    About the Society for Melanoma Research

    • The SMR is an organization of scientific and medical investigators devoted to alleviating the suffering of people with melanoma
    • It was founded to unify the field by increasing communication among researchers and building bridges of collaboration between basic, translational and clinical investigators
    • The SMR holds annual meetings to provide researchers an opportunity to collaborate, meet and share ideas about all forms of melanoma research

     

Viewing 8 reply threads
  • Replies
      • January 23, 2015 at 4:36 pm
      rick1981
      Participant

      Thanks, will have a look!

      • January 23, 2015 at 4:36 pm
      rick1981
      Participant

      Thanks, will have a look!

      • January 23, 2015 at 4:36 pm
      rick1981
      Participant

      Thanks, will have a look!

      • January 23, 2015 at 7:25 pm
      ed williams
      Participant

      Thanks Shelby, it was very informative and should give hope to many members of the forum. Ed

        • January 24, 2015 at 12:12 am
        Anonymous
        Inactive

        Hi Ed,

        I'm glad you were able to watch the webinar and that you enjoyed it. I hope you have a great weekend!

        Shelby – MRF

        • January 24, 2015 at 12:12 am
        Anonymous
        Inactive

        Hi Ed,

        I'm glad you were able to watch the webinar and that you enjoyed it. I hope you have a great weekend!

        Shelby – MRF

        • January 24, 2015 at 12:12 am
        Anonymous
        Inactive

        Hi Ed,

        I'm glad you were able to watch the webinar and that you enjoyed it. I hope you have a great weekend!

        Shelby – MRF

      • January 23, 2015 at 7:25 pm
      ed williams
      Participant

      Thanks Shelby, it was very informative and should give hope to many members of the forum. Ed

      • January 23, 2015 at 7:25 pm
      ed williams
      Participant

      Thanks Shelby, it was very informative and should give hope to many members of the forum. Ed

      • January 25, 2015 at 5:42 am
      Mat
      Participant

      Thanks for posting–very informative.  As a BRAFi-MEKi patient, I'll definitely look to follow the developments on HSP90 / XL88.

      • January 25, 2015 at 5:42 am
      Mat
      Participant

      Thanks for posting–very informative.  As a BRAFi-MEKi patient, I'll definitely look to follow the developments on HSP90 / XL88.

      • January 25, 2015 at 5:42 am
      Mat
      Participant

      Thanks for posting–very informative.  As a BRAFi-MEKi patient, I'll definitely look to follow the developments on HSP90 / XL88.

Viewing 8 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics